ChemoCentryx, Inc. EBITDA Margin 2012-2022 | CCXI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ChemoCentryx, Inc. (CCXI) over the last 10 years. The current EBITDA margin for ChemoCentryx, Inc. as of June 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-06-30 | $0.04B | $-0.13B | -343.24% |
| 2022-03-31 | $0.03B | $-0.13B | -496.30% |
| 2021-12-31 | $0.03B | $-0.13B | -393.75% |
| 2021-09-30 | $0.03B | $-0.12B | -344.12% |
| 2021-06-30 | $0.02B | $-0.12B | -576.19% |
| 2021-03-31 | $0.07B | $-0.06B | -91.18% |
| 2020-12-31 | $0.06B | $-0.06B | -85.94% |
| 2020-09-30 | $0.07B | $-0.04B | -58.57% |
| 2020-06-30 | $0.08B | $-0.03B | -40.79% |
| 2020-03-31 | $0.03B | $-0.07B | -200.00% |
| 2019-12-31 | $0.04B | $-0.06B | -161.11% |
| 2019-09-30 | $0.04B | $-0.05B | -148.57% |
| 2019-06-30 | $0.03B | $-0.05B | -151.52% |
| 2019-03-31 | $0.04B | $-0.04B | -100.00% |
| 2018-12-31 | $0.04B | $-0.04B | -90.70% |
| 2018-09-30 | $0.09B | $0.01B | 12.22% |
| 2018-06-30 | $0.09B | $0.02B | 16.67% |
| 2018-03-31 | $0.08B | $0.01B | 15.48% |
| 2017-12-31 | $0.08B | $0.02B | 20.73% |
| 2017-09-30 | $0.03B | $-0.03B | -96.77% |
| 2017-06-30 | $0.03B | $-0.03B | -115.38% |
| 2017-03-31 | $0.02B | $-0.03B | -155.00% |
| 2013-12-31 | $0.01B | $-0.04B | -542.86% |
| 2013-09-30 | $0.01B | $-0.04B | -462.50% |
| 2013-06-30 | $0.01B | $-0.04B | -557.14% |
| 2013-03-31 | $0.01B | $-0.04B | -683.33% |
| 2012-12-31 | $0.01B | $-0.04B | -780.00% |
| 2012-09-30 | $0.03B | $-0.01B | -34.48% |
| 2012-06-30 | $0.03B | $-0.01B | -27.59% |
| 2012-03-31 | $0.03B | $-0.01B | -17.24% |
| 2011-12-31 | $0.03B | $-0.00B | -9.68% |
